source Post navigation Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus … – The Lancet Shaking the Sodium Habit – A Small Change for Better Heart Health – storystudio.timesunion.com